Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Intarcia Therapeutics

Explore full profile

Develops innovative therapies aimed at Diabetes

Boston, United StatesFounded 1997Biotech & Life Sciences
Valuation $2.5–5B Last recorded · 2019
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $1–2.5B Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Intarcia Therapeutics and the history behind them.

About Intarcia Therapeutics

Intarcia Therapeutics is a pioneering company focused on redesigning the treatment of chronic diseases through innovative therapies that integrate medicine with technology. Operating in the biopharmaceutical sector, Intarcia serves patients suffering from chronic conditions, aiming to improve their quality of life with advanced drug delivery systems. The company's core product is the Medici Drug Delivery System, an investigational technology designed to provide consistent and long-term delivery of medication. Intarcia's business model revolves around the development and commercialization of these cutting-edge therapies, generating revenue through partnerships, licensing agreements, and direct sales. By placing patients at the center of their mission, Intarcia is committed to transforming therapeutic categories and setting new standards in chronic disease management.

Source: Dealroom company data

At a glance

Founded
1997
Headquarters
Boston, United States
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Latest news

Press, funding announcements and product moves mentioning Intarcia Therapeutics.

See all news

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later10 investors entered at this stage

Talent

Book a demo to see the people
Team profiled 32 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States93.5%
🇵🇰 Pakistan2.2%
🇮🇪 Ireland2.2%
🇮🇳 India2.2%
4 countries shown
Web traffic by country
930 monthly visits
across markets
🇺🇸 United States96.8%
Top 1 markets shown

Patents

Estimated portfolio value
$49M

21 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Intarcia Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Intarcia Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles